Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « November » « 2025 » M T W T F S S 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30   - « November » « 2025 » M T W T F S S 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HUANG, Yong
NCT06245941: A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)	Recruiting	1/2	93	RoW	TQ05105 tablets, TQB3909 tablets	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Myelofibrosis	06/26	05/27
TQB2928-AK105-Ib-01, NCT06297642: TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.	Terminated	1	3	RoW	TQB2928 injection, Penpulimab	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Advanced Malignant Neoplasm	07/24	07/24
DILI-P, NCT02961413: A Prospective Cohort Study on Drug-induced Liver Injury in China（）	Recruiting	N/A	10000	RoW		Drug Induced Liver Disease Study Group	Drug-induced Liver Injury	12/30	12/30

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HUANG, Yong
NCT06245941: A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)	Recruiting	1/2	93	RoW	TQ05105 tablets, TQB3909 tablets	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Myelofibrosis	06/26	05/27
TQB2928-AK105-Ib-01, NCT06297642: TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.	Terminated	1	3	RoW	TQB2928 injection, Penpulimab	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Advanced Malignant Neoplasm	07/24	07/24
DILI-P, NCT02961413: A Prospective Cohort Study on Drug-induced Liver Injury in China（）	Recruiting	N/A	10000	RoW		Drug Induced Liver Disease Study Group	Drug-induced Liver Injury	12/30	12/30